We partner with leading universities, hospitals, and HCPs to investigate our novel NanoCelle® therapies.

The ENHANCE Study
A national observational study aimed to investigate the ability of NanoCelle® THC/CBD
to safely reduce the severity of chronic conditions and enhance quality of life.
Patient recruitment is planned to start in March 2023.